Edition:
United States

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

4.87USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,954
52-wk High
$13.87
52-wk Low
$4.85

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $174.23
Shares Outstanding(Mil.): 29.28
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.97 -- --
ROI: -45.13 0.60 13.80
ROE: -45.50 -2.18 15.29

Earnings vs. Estimates